Corticosteroid-induced adverse events in adults: frequency, screening and prevention.
about
Current Concepts in the Management of Rheumatoid HandBacterial Meningitis in Patients using Immunosuppressive Medication: a Population-based Prospective Nationwide StudyUse of dexamethasone in patients with high-grade glioma: a clinical practice guidelineDepression subtypes in pediatric inflammatory bowel disease.Factors associated with the initiation of proton pump inhibitors in corticosteroid users.Current concepts in the management of the rheumatoid hand.A preclinical canine model for composite tissue transplantationClinical practice guideline: hoarseness (dysphonia).Characterisation of non-obese diabetic patients with marked insulin resistance identifies a novel familial partial lipodystrophy-associated PPARγ mutation (Y151C).Posterior Reversible Encephalopathy Syndrome due to High Dose Corticosteroids for an MS Relapse.Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses.Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry.[Prevalence of complications of corticosteroid therapy among West African consulting in rheumatology].Treatment of acute relapses in multiple sclerosis.Ovarian Damage During chemotherapy in Autoimmune Diseases: Broad Health Implications beyond Fertility.Post-operative severe hypokalemia mimicking myocardial ischemiaA Pilot Study Evaluating Steroid-Induced Diabetes after Antiemetic Dexamethasone Therapy in Chemotherapy-Treated Cancer Patients.Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management.Fluticasone, azithromycin and montelukast therapy in reducing corticosteroid exposure in bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: a case series of eight patientsWhat's new in atopic eczema?What rhinologists and allergists should know about the medico-legal implications of corticosteroid use: a review of the literature.Glucocorticoid therapy for gastrointestinal diseases.What is new in atopic dermatitis/eczema?Systemic glucocorticoids: important issues and practical guidelines for the dermatologist.Prevalence and prescription patterns of oral glucocorticoids in adults: a retrospective cross-sectional and cohort analysis in FranceSynthesis, toxicity study and anti-inflammatory effect of MHTP, a new tetrahydroisoquinoline alkaloid.Evaluation of anti-atopic dermatitis activity of Hypsizigus marmoreus extract.Multimorbidity in bullous pemphigoid: a case-control analysis of bullous pemphigoid patients with age- and gender-matched controls.Factors influencing intercellular spaces in the rat esophageal epithelium.Treatment of Non-infectious Uveitic Macular Edema with the Intravitreal Dexamethasone Implant.Decisional support to prevent adverse drug reactions of long latency: pilot randomized controlled intervention for glucocorticoid-induced diabetes.Using Systems Biology-based Analysis Approaches to Identify Mechanistically Significant Adverse Drug Reactions: Pulmonary Complications from Combined Use of Anti-TNFα Agents and Corticosteroids.Zoledronic Acid, Bevacizumab and Dexamethasone-Induced Apoptosis, Mitochondrial Oxidative Stress, and Calcium Signaling Are Decreased in Human Osteoblast-Like Cell Line by Selenium Treatment.Treatment of refractory uveitic macular edema: results of a first and second implant of long-acting intravitreal dexamethasone.Effects of short-term oral corticosteroid intake on dietary intake, body weight and body composition in adults with asthma - a randomized controlled trial.Health-related quality of life associated with systemic corticosteroids.Longitudinal study of short-term corticosteroid use by working-age adults with diabetes mellitus: Risks and mitigating factors.The impact of long-term systemic glucocorticoid use in severe asthma: A UK retrospective cohort analysis.Olfaction in chronic rhinosinusitis: comparing two different endonasal steroid application methods.Dexamethasone promotes long-term functional recovery of neuromuscular junction in a murine model of tourniquet-induced ischaemia-reperfusion.
P2860
Q26799958-FABF6B8B-394A-4C50-A15B-37484FBA41B3Q33603327-2AD12D94-A346-495F-A693-DBCECB3030EEQ33763941-A6843540-3646-41A4-8D5F-B8ACDE8D76ACQ33963625-42474207-0F7D-47E3-B123-F60FC39025E5Q34141425-F02AB475-11FA-49FB-A2FF-91B0AEFCA485Q34175681-5B7D19BC-E14A-456F-A115-032FFAB19BEDQ34286899-8EE57417-6CAB-40BC-BF20-582B4EE5A3B4Q35001102-2169FB10-0082-4EAE-B88C-092FAAACC7A7Q35031653-B1993822-575A-4DDA-B3E9-ABF774E5C791Q35697597-A65C1A1E-0F8D-4173-B99A-6CD249805454Q35811145-C0343669-A2F5-4748-BFF6-2999DDB3DA12Q35906666-7B2AD489-6DF6-41F1-A40C-9E333BDAB756Q36250388-6436B467-0983-4D30-ABDF-BC60C5B652C9Q36568671-E9F01DA8-55D8-4E7E-A062-600497B6D34DQ37105605-8A24E316-0F2B-41B7-8AFE-84CB4579431DQ37286194-07885774-EDF0-4DCF-BC77-6BB2AC5646C8Q37367496-FC902F1C-0E97-46DE-A0E6-ABE2C147D823Q37374868-C37E77A7-53FE-435C-89AE-7739840FCA17Q37703430-5BABED4A-BC10-4993-B5A5-54548388BBEAQ37740142-E8716010-660B-4738-9A06-9C32EA34E057Q37976663-AC8519E6-0EC9-4A80-B283-E5E979CADEA4Q38205264-199D4C9B-8623-4E9A-82E4-A9568B61D5D2Q38257104-41053063-8750-4AA8-AD00-1BF7322FE76FQ38356324-06F5C349-9E1C-4BE5-9FCF-77596D0B9921Q38650895-9CA3F9E4-9217-4DEC-8DA9-CD028E96776BQ38981137-D10CCE80-BAA1-4E9E-B131-F38988026698Q38993885-DBDB144F-A211-42F5-B736-8460078FC6A5Q39293554-9328DCA9-F4FD-40F5-8276-B71E6A05E8F9Q39529832-6F3DBBDB-0820-4050-87B3-EF4AF6722456Q39898518-5381CC4D-9C03-4AE5-BA66-15D714BC8007Q41104118-CA2DCE17-52E1-49AE-8B2F-F850CA00BFF8Q42925553-71C20359-2055-4E3A-B386-15C2C28C5D01Q46272591-43D3DECF-BF4C-411A-BC49-8B2D4A0A5A65Q47145465-90703780-E948-40CB-93FF-58F2A228C86CQ47408523-9D5AA8AC-1A8E-4822-8E51-5894A0B18A54Q47640135-C4F9EA5F-6342-474A-AC22-56A419F34B14Q47691007-902466F2-8B7E-45B3-A9C3-5706C87C350DQ47769040-558E2F95-8F77-46CB-8E7F-298A3073174BQ51140225-63EE09B8-974B-42F4-A71E-42D086528AB6Q51290274-25A5D5B1-299E-4EF1-B005-6C4984278BDD
P2860
Corticosteroid-induced adverse events in adults: frequency, screening and prevention.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Corticosteroid-induced adverse events in adults: frequency, screening and prevention.
@en
type
label
Corticosteroid-induced adverse events in adults: frequency, screening and prevention.
@en
prefLabel
Corticosteroid-induced adverse events in adults: frequency, screening and prevention.
@en
P2093
P1433
P1476
Corticosteroid-induced adverse events in adults: frequency, screening and prevention.
@en
P2093
Abdulrhaman Kassar
Jean Cabane
Laurence Fardet
P304
P356
10.2165/00002018-200730100-00005
P577
2007-01-01T00:00:00Z
P6179
1038131077